StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > US$40 million Agreement

<< Previous

Bullboard Posts

Next >>

Comment by BankBenjaminson Feb 15, 2021 5:03pm

146 Views

Post# 32569553

RE:RE:RE:RE:RE:RE:US$40 million Agreement

Oh forgot to mention the other stock I had to sell was li auto bc of the delisting bill that came. As well as I was a noob for looking at stock forecast more than anything else initially so I passed on transenterix when it was at .53 cents at the time it said it was only going to go up 18%. I probably looked at 15-20 stocks in total. Seems to be just luck. I have made more cash with 10 000 in 4 months than most will make in years. Check out SCR for a great hold this year. Glta

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages